A cream of herbal mixture to improve melasma
Summary Background Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate. Objective To investigate the safety and efficacy of a cream containing herbal mixture for melasma. Methods A total of 90 volunteers with...
Saved in:
Published in | Journal of cosmetic dermatology Vol. 18; no. 6; pp. 1721 - 1728 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley and Sons Inc
01.12.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1473-2130 1473-2165 1473-2165 |
DOI | 10.1111/jocd.12938 |
Cover
Abstract | Summary
Background
Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate.
Objective
To investigate the safety and efficacy of a cream containing herbal mixture for melasma.
Methods
A total of 90 volunteers with melasma were enrolled in this randomized, double‐blind, controlled clinical study, and they were randomly divided into three groups (A, B, and C). Patients in group A were treated with a cream containing herbal mixture, while groups B and C were treated with arbutin cream and placebo, respectively, twice daily for 12 weeks. Melasma area and severity index (MASI) score, melanin index (MI), erythema index (EI), changes in density of inflammatory cells, and adverse events were evaluated every 4 weeks.
Results
Although MASI scores declined significantly in both groups A and B (P < 0.05), a greater reduction was seen in group A (13.00−9.82 = 3.18 for group A; 12.65−10.84 = 1.81 for group B). Moreover, the cream containing herbal mixture, but not arbutin cream and placebo, significantly reduced EI and density of inflammatory cells after 12‐week treatment (P < 0.05). No adverse reactions were observed in either group A or group C. In group B, two subjects experienced mild erythema and itching, which disappeared after stop using the arbutin cream.
Conclusion
The cream containing herbal mixture is safe and effective for melasma. |
---|---|
AbstractList | Summary
Background
Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate.
Objective
To investigate the safety and efficacy of a cream containing herbal mixture for melasma.
Methods
A total of 90 volunteers with melasma were enrolled in this randomized, double‐blind, controlled clinical study, and they were randomly divided into three groups (A, B, and C). Patients in group A were treated with a cream containing herbal mixture, while groups B and C were treated with arbutin cream and placebo, respectively, twice daily for 12 weeks. Melasma area and severity index (MASI) score, melanin index (MI), erythema index (EI), changes in density of inflammatory cells, and adverse events were evaluated every 4 weeks.
Results
Although MASI scores declined significantly in both groups A and B (P < 0.05), a greater reduction was seen in group A (13.00−9.82 = 3.18 for group A; 12.65−10.84 = 1.81 for group B). Moreover, the cream containing herbal mixture, but not arbutin cream and placebo, significantly reduced EI and density of inflammatory cells after 12‐week treatment (P < 0.05). No adverse reactions were observed in either group A or group C. In group B, two subjects experienced mild erythema and itching, which disappeared after stop using the arbutin cream.
Conclusion
The cream containing herbal mixture is safe and effective for melasma. Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate.BACKGROUNDMelasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate.To investigate the safety and efficacy of a cream containing herbal mixture for melasma.OBJECTIVETo investigate the safety and efficacy of a cream containing herbal mixture for melasma.A total of 90 volunteers with melasma were enrolled in this randomized, double-blind, controlled clinical study, and they were randomly divided into three groups (A, B, and C). Patients in group A were treated with a cream containing herbal mixture, while groups B and C were treated with arbutin cream and placebo, respectively, twice daily for 12 weeks. Melasma area and severity index (MASI) score, melanin index (MI), erythema index (EI), changes in density of inflammatory cells, and adverse events were evaluated every 4 weeks.METHODSA total of 90 volunteers with melasma were enrolled in this randomized, double-blind, controlled clinical study, and they were randomly divided into three groups (A, B, and C). Patients in group A were treated with a cream containing herbal mixture, while groups B and C were treated with arbutin cream and placebo, respectively, twice daily for 12 weeks. Melasma area and severity index (MASI) score, melanin index (MI), erythema index (EI), changes in density of inflammatory cells, and adverse events were evaluated every 4 weeks.Although MASI scores declined significantly in both groups A and B (P < 0.05), a greater reduction was seen in group A (13.00-9.82 = 3.18 for group A; 12.65-10.84 = 1.81 for group B). Moreover, the cream containing herbal mixture, but not arbutin cream and placebo, significantly reduced EI and density of inflammatory cells after 12-week treatment (P < 0.05). No adverse reactions were observed in either group A or group C. In group B, two subjects experienced mild erythema and itching, which disappeared after stop using the arbutin cream.RESULTSAlthough MASI scores declined significantly in both groups A and B (P < 0.05), a greater reduction was seen in group A (13.00-9.82 = 3.18 for group A; 12.65-10.84 = 1.81 for group B). Moreover, the cream containing herbal mixture, but not arbutin cream and placebo, significantly reduced EI and density of inflammatory cells after 12-week treatment (P < 0.05). No adverse reactions were observed in either group A or group C. In group B, two subjects experienced mild erythema and itching, which disappeared after stop using the arbutin cream.The cream containing herbal mixture is safe and effective for melasma.CONCLUSIONThe cream containing herbal mixture is safe and effective for melasma. Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate. To investigate the safety and efficacy of a cream containing herbal mixture for melasma. A total of 90 volunteers with melasma were enrolled in this randomized, double-blind, controlled clinical study, and they were randomly divided into three groups (A, B, and C). Patients in group A were treated with a cream containing herbal mixture, while groups B and C were treated with arbutin cream and placebo, respectively, twice daily for 12 weeks. Melasma area and severity index (MASI) score, melanin index (MI), erythema index (EI), changes in density of inflammatory cells, and adverse events were evaluated every 4 weeks. Although MASI scores declined significantly in both groups A and B (P < 0.05), a greater reduction was seen in group A (13.00-9.82 = 3.18 for group A; 12.65-10.84 = 1.81 for group B). Moreover, the cream containing herbal mixture, but not arbutin cream and placebo, significantly reduced EI and density of inflammatory cells after 12-week treatment (P < 0.05). No adverse reactions were observed in either group A or group C. In group B, two subjects experienced mild erythema and itching, which disappeared after stop using the arbutin cream. The cream containing herbal mixture is safe and effective for melasma. |
Author | Tu, Ying Sun, Dongjie Chen, Hongduo Zhang, Qiongyu He, Li Gu, Hua Wu, Wenjuan Man, Mao‐Qiang Liu, Haiyang Ma, Xiao |
AuthorAffiliation | 3 Department of Dermatology University of California San Francisco San Francisco California 4 Department of Dermatology The First Hospital of China Medical University Shenyang China 2 Dermatology Service Veterans Affairs Medical Center San Francisco San Francisco California 6 Beitaini Bio‐technological Co Ltd Kunming China 1 Department of Dermatology First Affiliated Hospital of Kunming Medical University Kunming China 5 State Key Laboratory of Phytochemistry and Plant Resources in West China Kunming Institute of Botany, Chinese Academy of Sciences Kunming China |
AuthorAffiliation_xml | – name: 2 Dermatology Service Veterans Affairs Medical Center San Francisco San Francisco California – name: 3 Department of Dermatology University of California San Francisco San Francisco California – name: 5 State Key Laboratory of Phytochemistry and Plant Resources in West China Kunming Institute of Botany, Chinese Academy of Sciences Kunming China – name: 6 Beitaini Bio‐technological Co Ltd Kunming China – name: 4 Department of Dermatology The First Hospital of China Medical University Shenyang China – name: 1 Department of Dermatology First Affiliated Hospital of Kunming Medical University Kunming China |
Author_xml | – sequence: 1 givenname: Qiongyu orcidid: 0000-0001-6306-5379 surname: Zhang fullname: Zhang, Qiongyu organization: First Affiliated Hospital of Kunming Medical University – sequence: 2 givenname: Ying surname: Tu fullname: Tu, Ying organization: First Affiliated Hospital of Kunming Medical University – sequence: 3 givenname: Hua surname: Gu fullname: Gu, Hua organization: First Affiliated Hospital of Kunming Medical University – sequence: 4 givenname: Dongjie surname: Sun fullname: Sun, Dongjie organization: First Affiliated Hospital of Kunming Medical University – sequence: 5 givenname: Wenjuan surname: Wu fullname: Wu, Wenjuan organization: First Affiliated Hospital of Kunming Medical University – sequence: 6 givenname: Mao‐Qiang orcidid: 0000-0002-0957-4903 surname: Man fullname: Man, Mao‐Qiang organization: University of California San Francisco – sequence: 7 givenname: Hongduo surname: Chen fullname: Chen, Hongduo organization: The First Hospital of China Medical University – sequence: 8 givenname: Haiyang surname: Liu fullname: Liu, Haiyang organization: Kunming Institute of Botany, Chinese Academy of Sciences – sequence: 9 givenname: Xiao surname: Ma fullname: Ma, Xiao organization: Beitaini Bio‐technological Co Ltd – sequence: 10 givenname: Li surname: He fullname: He, Li email: drheli2662@126.com organization: First Affiliated Hospital of Kunming Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30980618$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kVtPwyAcxYmZcRd98QOYPhpjJ5eWwYvJMu9Zshd9JpRSx9KWCe10397ObosaIy9A-J1zwv_0Qae0pQbgFMEhatbVwqp0iDAn7AD0UDQiIUY07uzPBHZB3_sFhGjEUXwEugRyBiliPXA5DpTTsghsFsy1S2QeFOajqp0OKhuYYunsSgeFzqUv5DE4zGTu9cl2H4CXu9vnyUM4nd0_TsbTUEWMslAplMgRjCNCM8SiJONSs5QkmMYEa5SpUXPnWDIUkxTHkcwkjWIWRRjCJEsoGYDr1ndZJ4VOlS4rJ3OxdKaQbi2sNOLnS2nm4tWuBOXNx2PeGJxvDZx9q7WvRGG80nkuS21rLzCGnKJmPLBBz75n7UN2I2oA2ALKWe-dzoQylayM3USbXCAoNi2ITQviq4VGcvFLsnP9E0Yt_G5yvf6HFE-zyU2r-QRQbpcG |
CitedBy_id | crossref_primary_10_1007_s10661_022_09786_z crossref_primary_10_1111_bjd_21244 crossref_primary_10_1111_jocd_13799 crossref_primary_10_1016_j_bbrep_2023_101530 crossref_primary_10_52711_0974_360X_2021_01061 crossref_primary_10_1080_09546634_2021_1914313 crossref_primary_10_1111_jocd_13610 crossref_primary_10_1016_j_heliyon_2023_e22421 crossref_primary_10_1111_jocd_16741 crossref_primary_10_1111_jocd_70007 crossref_primary_10_1111_jocd_15632 crossref_primary_10_1111_jocd_16710 crossref_primary_10_5650_jos_ess21262 crossref_primary_10_1097_JD9_0000000000000164 crossref_primary_10_3389_fphar_2024_1337282 crossref_primary_10_1016_j_jtcms_2024_12_003 crossref_primary_10_1016_j_hermed_2024_100880 crossref_primary_10_1016_j_heliyon_2024_e28096 crossref_primary_10_3389_fmed_2021_797890 crossref_primary_10_1007_s40257_024_00863_2 |
Cites_doi | 10.1111/ajd.12290 10.1111/1346-8138.12573 10.1111/jdv.12049 10.1111/j.1473-2165.2012.00613.x 10.1111/j.2042-7158.1998.tb02427.x 10.1016/j.phrs.2018.05.005 10.1097/DAD.0b013e3181ef2d45 10.1111/j.1600-0536.1994.tb01914.x 10.1016/j.jdermsci.2007.01.009 10.1001/archderm.1994.01690060057005 10.4172/2376-0427.1000127 10.1111/jdv.12051 10.1016/S0190-9622(81)70071-9 10.1007/s13555-017-0194-1 10.3390/ijms12042618 10.1097/DAD.0000000000000378 10.1038/jid.2011.109 10.1111/j.2042-7158.1998.tb02426.x 10.4103/0378-6323.98071 10.1046/j.0007-0963.2001.04556.x 10.1080/19476337.2017.1343867 10.1111/j.1600-0625.2009.01057.x 10.1016/j.dsi.2015.04.009 10.1111/j.1468-3083.2011.04337.x 10.1046/j.1365-4362.2003.01621.x |
ContentType | Journal Article |
Copyright | 2019 The Authors. Published by Wiley Periodicals, Inc. 2019 The Authors. Journal of Cosmetic Dermatology Published by Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2019 The Authors. Published by Wiley Periodicals, Inc. – notice: 2019 The Authors. Journal of Cosmetic Dermatology Published by Wiley Periodicals, Inc. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1111/jocd.12938 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | ZHANG et al |
EISSN | 1473-2165 |
EndPage | 1728 |
ExternalDocumentID | PMC6916559 30980618 10_1111_jocd_12938 JOCD12938 |
Genre | article Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: Major science and technology projects in Yunnan Province China funderid: 2018ZF005 – fundername: Science and Technology Leadership Talent Project in Yunnan China funderid: 2017HA010 – fundername: Program for Innovative Research Team, the Ministry of Education of China funderid: IRT17-R49 – fundername: Science and Technology Leadership Talent Project in Yunnan China grantid: 2017HA010 – fundername: Major science and technology projects in Yunnan Province China grantid: 2018ZF005 – fundername: Program for Innovative Research Team, the Ministry of Education of China grantid: IRT17-R49 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFZJQ AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY Q.N QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM YFH YUY ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PUEGO CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c4868-cc1ba705436f184bf9ae8d3b26532e1fc7ae892a8153d254afa645844200bfb63 |
IEDL.DBID | 24P |
ISSN | 1473-2130 1473-2165 |
IngestDate | Thu Aug 21 18:21:40 EDT 2025 Thu Jul 10 23:37:28 EDT 2025 Mon Jul 21 05:44:09 EDT 2025 Wed Oct 01 03:17:13 EDT 2025 Thu Apr 24 23:03:57 EDT 2025 Wed Jan 22 16:38:00 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | erythema index herbal mixture melasma area and severity index score melasma melanin index |
Language | English |
License | Attribution 2019 The Authors. Journal of Cosmetic Dermatology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4868-cc1ba705436f184bf9ae8d3b26532e1fc7ae892a8153d254afa645844200bfb63 |
Notes | Funding information This work was supported by Program for Innovative Research Team, the Ministry of Education of China (IRT17‐R49), Major science and technology projects in Yunnan Province China (2018ZF005), and Science and Technology Leadership Talent Project in Yunnan China (2017HA010). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Zhang and Tu contributed equally to this work |
ORCID | 0000-0001-6306-5379 0000-0002-0957-4903 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.12938 |
PMID | 30980618 |
PQID | 2209611470 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6916559 proquest_miscellaneous_2209611470 pubmed_primary_30980618 crossref_citationtrail_10_1111_jocd_12938 crossref_primary_10_1111_jocd_12938 wiley_primary_10_1111_jocd_12938_JOCD12938 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2019 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Hoboken |
PublicationTitle | Journal of cosmetic dermatology |
PublicationTitleAlternate | J Cosmet Dermatol |
PublicationYear | 2019 |
Publisher | John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley and Sons Inc |
References | 2015; 56 2017; 7 2015; 37 2013; 27 2010; 19 1994; 130 2015; 33 1981; 4 2004; 24 2011; 33 2011; 12 2014; 41 2008; 1 2012; 34 2012; 78 2012; 11 2011; 131 2018; 24 2015; 46 2014; 1 2015; 48 2002; 146 2018; 134 2017; 34 2011; 50 2017; 19 2012; 26 2012; 45 2007; 46 2003; 42 2018; 16 1994; 31 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 Wang YJ (e_1_2_7_13_1) 2017; 34 e_1_2_7_9_1 Wang YJ (e_1_2_7_7_1) 2015; 48 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_12_1 Wang Y (e_1_2_7_20_1) 2015; 46 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Yan QF (e_1_2_7_31_1) 2008; 1 Huang XF (e_1_2_7_19_1) 2015; 48 Wang J (e_1_2_7_30_1) 2004; 24 Yang J (e_1_2_7_33_1) 2017; 19 e_1_2_7_25_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_34_1 e_1_2_7_35_1 e_1_2_7_36_1 Pang Q (e_1_2_7_21_1) 2012; 34 Tu Y (e_1_2_7_22_1) 2012; 45 Zhang QY (e_1_2_7_24_1) 2018; 24 |
References_xml | – volume: 24 start-page: 274 issue: 4 year: 2018 end-page: 278 article-title: Clinical staging of melasma publication-title: Chin J Med Aesthet Cosmet – volume: 50 start-page: 227 year: 2011 end-page: 231 article-title: Evaluation of anti‐inflammatory activity of Portulaca species publication-title: J Pharmacy Pharm – volume: 34 start-page: 468 issue: 04 year: 2017 end-page: 472 article-title: Explore the possible mechanism of epidermal permeability barrier dysfunction in melasma publication-title: China Med Abstr Dermatol – volume: 48 start-page: 100 issue: 2 year: 2015 end-page: 103 article-title: Expressions of toll‐like receptors 2 and 4 in skin lesions and peripheral blood from patients with chloasma publication-title: Chin J Dermatol – volume: 46 start-page: 1381 issue: 09 year: 2015 end-page: 1392 article-title: Advances in study on saponins in manax notoginseng and their pharmacological activities publication-title: Chin Trad Herb Drug – volume: 31 start-page: 57 issue: 1 year: 1994 end-page: 58 article-title: Exogenous ochronosis with allergic contact dermatitis from hydroquinone publication-title: Contact Dermatitis – volume: 16 start-page: 105 issue: 1 year: 2018 end-page: 112 article-title: Ultrasonic‐assisted extraction and antioxidant capacities of flavonoids from Camellia fascicularis leaves publication-title: CyTA J Food – volume: 50 start-page: 226 year: 2011 end-page: 230 article-title: K. Evaluation of analgesic activity of the aerial parts of Portulaca oleracea v. sativa and its comparison with two related spices publication-title: J Pharmacy Pharm – volume: 42 start-page: 153 issue: 2 year: 2003 end-page: 156 article-title: A clinical, prospective, randomized, double‐blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma publication-title: Int J Dermatol – volume: 34 start-page: 318 year: 2012 end-page: 322 article-title: Research in anti‐inflammation function by various extracted method and concentration of Portulaca oleracea publication-title: Dermatol Venereol – volume: 37 start-page: 761 issue: 10 year: 2015 end-page: 766 article-title: CD4, IL‐17, and COX‐2 are associated with subclinical inflammation in malar melasma publication-title: Am J Dermatopathol – volume: 130 start-page: 727 issue: 6 year: 1994 end-page: 733 article-title: Topical retinoic acid (Tretinoin) for melasma in black patients publication-title: Arch Dermatol – volume: 12 start-page: 2618 issue: 4 year: 2011 end-page: 2630 article-title: Antioxidant effects of the ethanol extract from flower of Camellia japonica via scavenging of reactive oxygen species and induction of antioxidant enzymes publication-title: Int J Mol Sci – volume: 45 start-page: 718 year: 2012 end-page: 722 article-title: Effects of Prinsepia utilis Royle oil on the synthesis of ceramide and expression of ceramidase publication-title: Chin J Dermatol – volume: 48 start-page: 133 issue: 2 year: 2015 end-page: 136 article-title: Effects of Camellia retic ulata, Chloranthus japonicas, Dodonaea viscosa and Paris polyphylla on the proliferation of and tyrosinase activity in a melanocyte cell line publication-title: Chin J Dermatol – volume: 19 start-page: 1641 issue: 10 year: 2017 end-page: 1647 article-title: Research progress of chemical composition and pharmacological actions of Panax notoginseng publication-title: Modern Trad Chin Med Materia Med World Sci Technol – volume: 33 start-page: 291 issue: 3 year: 2011 end-page: 295 article-title: Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane publication-title: Am J Dermatopathol – volume: 4 start-page: 698 issue: 6 year: 1981 end-page: 710 article-title: Melasma: a clinical, light microscopic, ultrastructural, and immunofluores‐cence study publication-title: J Am Acad Dermatol – volume: 27 start-page: 19 issue: Suppl 1 year: 2013 end-page: 23 article-title: 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation publication-title: J Eur Acad Dermatol Venereol – volume: 11 start-page: 151 issue: 2 year: 2012 end-page: 157 article-title: Melasma in men publication-title: J Cosmetic Dermatol – volume: 46 start-page: 111 issue: 2 year: 2007 end-page: 116 article-title: The vascular characteristics of melasma publication-title: J Dermatol Sci – volume: 24 start-page: 312 issue: 4 year: 2004 end-page: 316 article-title: Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome publication-title: Chin J Integr Med – volume: 19 start-page: e228 issue: 8 year: 2010 end-page: e233 article-title: In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution publication-title: Exp Dermatol – volume: 41 start-page: 788 issue: 9 year: 2014 end-page: 794 article-title: Inflammatory features of melasma lesions in Asian skin publication-title: J Dermatol – volume: 56 start-page: 151 issue: 3 year: 2015 end-page: 163 article-title: Melasma: clinical diagnosis and management options publication-title: Australas J Dermatol – volume: 78 start-page: 417 issue: 4 year: 2012 end-page: 428 article-title: Newer and upcoming therapies for melasma publication-title: Indian J Dermatol Venereol Leprol – volume: 1 start-page: 56 year: 2008 end-page: 57 article-title: Influence of Panax notoginseng saponins on serums ICAM‐1 in patients with acute cerebral infarction publication-title: Chin J Pract Nerv Dis – volume: 33 start-page: 90 year: 2015 end-page: 95 article-title: Herbal medicines that benefit epidermal permeability barrier function publication-title: Dermatol Sin – volume: 27 start-page: 5 issue: Suppl 1 year: 2013 end-page: 6 article-title: Melasma pathogenesis and influencing factors ‐ an overview of the latest research publication-title: J Eur Acad Dermatol Venereol – volume: 1 start-page: 127 year: 2014 article-title: Melanocytes and oxidative stress publication-title: J Pigment Disord – volume: 7 start-page: 305 issue: 3 year: 2017 end-page: 318 article-title: Melasma: an up‐to‐date comprehensive review publication-title: Dermatol Ther (Heidelb) – volume: 26 start-page: 1533 issue: 12 year: 2012 end-page: 1537 article-title: Defective barrier function in melasma skin publication-title: J Eur Acad Dermatol Venereol – volume: 134 start-page: 1 year: 2018 end-page: 15 article-title: Identification of certain Panax species to be potential substitutes for Panax notoginseng in hemostatic treatments publication-title: Pharmacol Res – volume: 146 start-page: 228 issue: 2 year: 2002 end-page: 237 article-title: Melasma: histopathological characteristics in 56 Korean patients publication-title: Br J Dermatol – volume: 131 start-page: 1692 issue: 8 year: 2011 end-page: 1700 article-title: Transcriptional profiling shows altered expression of wnt pathway‐ and lipid metabolism‐related genes as well as melanogenesis‐related genes in melasma publication-title: J Invest Dermatol – ident: e_1_2_7_4_1 doi: 10.1111/ajd.12290 – volume: 46 start-page: 1381 issue: 09 year: 2015 ident: e_1_2_7_20_1 article-title: Advances in study on saponins in manax notoginseng and their pharmacological activities publication-title: Chin Trad Herb Drug – ident: e_1_2_7_10_1 doi: 10.1111/1346-8138.12573 – volume: 48 start-page: 133 issue: 2 year: 2015 ident: e_1_2_7_19_1 article-title: Effects of Camellia retic ulata, Chloranthus japonicas, Dodonaea viscosa and Paris polyphylla on the proliferation of and tyrosinase activity in a melanocyte cell line publication-title: Chin J Dermatol – volume: 19 start-page: 1641 issue: 10 year: 2017 ident: e_1_2_7_33_1 article-title: Research progress of chemical composition and pharmacological actions of Panax notoginseng publication-title: Modern Trad Chin Med Materia Med World Sci Technol – ident: e_1_2_7_12_1 doi: 10.1111/jdv.12049 – ident: e_1_2_7_3_1 doi: 10.1111/j.1473-2165.2012.00613.x – ident: e_1_2_7_34_1 doi: 10.1111/j.2042-7158.1998.tb02427.x – ident: e_1_2_7_32_1 doi: 10.1016/j.phrs.2018.05.005 – ident: e_1_2_7_16_1 doi: 10.1097/DAD.0b013e3181ef2d45 – ident: e_1_2_7_17_1 doi: 10.1111/j.1600-0536.1994.tb01914.x – volume: 45 start-page: 718 year: 2012 ident: e_1_2_7_22_1 article-title: Effects of Prinsepia utilis Royle oil on the synthesis of ceramide and expression of ceramidase publication-title: Chin J Dermatol – ident: e_1_2_7_11_1 doi: 10.1016/j.jdermsci.2007.01.009 – volume: 48 start-page: 100 issue: 2 year: 2015 ident: e_1_2_7_7_1 article-title: Expressions of toll‐like receptors 2 and 4 in skin lesions and peripheral blood from patients with chloasma publication-title: Chin J Dermatol – ident: e_1_2_7_23_1 doi: 10.1001/archderm.1994.01690060057005 – volume: 34 start-page: 468 issue: 04 year: 2017 ident: e_1_2_7_13_1 article-title: Explore the possible mechanism of epidermal permeability barrier dysfunction in melasma publication-title: China Med Abstr Dermatol – volume: 24 start-page: 274 issue: 4 year: 2018 ident: e_1_2_7_24_1 article-title: Clinical staging of melasma publication-title: Chin J Med Aesthet Cosmet – ident: e_1_2_7_29_1 doi: 10.4172/2376-0427.1000127 – ident: e_1_2_7_18_1 doi: 10.1111/jdv.12051 – ident: e_1_2_7_2_1 doi: 10.1016/S0190-9622(81)70071-9 – volume: 34 start-page: 318 year: 2012 ident: e_1_2_7_21_1 article-title: Research in anti‐inflammation function by various extracted method and concentration of Portulaca oleracea publication-title: Dermatol Venereol – ident: e_1_2_7_5_1 doi: 10.1007/s13555-017-0194-1 – ident: e_1_2_7_27_1 doi: 10.3390/ijms12042618 – volume: 24 start-page: 312 issue: 4 year: 2004 ident: e_1_2_7_30_1 article-title: Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome publication-title: Chin J Integr Med – ident: e_1_2_7_9_1 doi: 10.1097/DAD.0000000000000378 – volume: 1 start-page: 56 year: 2008 ident: e_1_2_7_31_1 article-title: Influence of Panax notoginseng saponins on serums ICAM‐1 in patients with acute cerebral infarction publication-title: Chin J Pract Nerv Dis – ident: e_1_2_7_15_1 doi: 10.1038/jid.2011.109 – ident: e_1_2_7_35_1 doi: 10.1111/j.2042-7158.1998.tb02426.x – ident: e_1_2_7_25_1 doi: 10.4103/0378-6323.98071 – ident: e_1_2_7_6_1 doi: 10.1046/j.0007-0963.2001.04556.x – ident: e_1_2_7_28_1 doi: 10.1080/19476337.2017.1343867 – ident: e_1_2_7_8_1 doi: 10.1111/j.1600-0625.2009.01057.x – ident: e_1_2_7_36_1 doi: 10.1016/j.dsi.2015.04.009 – ident: e_1_2_7_14_1 doi: 10.1111/j.1468-3083.2011.04337.x – ident: e_1_2_7_26_1 doi: 10.1046/j.1365-4362.2003.01621.x |
SSID | ssj0017915 |
Score | 2.3130789 |
Snippet | Summary
Background
Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is... Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is moderate. To investigate... Melasma is an acquired, common hyperpigmented disorder on the face. While many therapeutic approaches are available, their efficacy is... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1721 |
SubjectTerms | Administration, Cutaneous Adult Double-Blind Method Drugs, Chinese Herbal - administration & dosage Drugs, Chinese Herbal - adverse effects erythema index Female herbal mixture Humans Male melanin index Melanosis - diagnosis Melanosis - drug therapy melasma melasma area and severity index score Middle Aged Original Contribution Severity of Illness Index Skin Care Skin Cream - administration & dosage Skin Cream - adverse effects Skin Pigmentation - drug effects Treatment Outcome |
Title | A cream of herbal mixture to improve melasma |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.12938 https://www.ncbi.nlm.nih.gov/pubmed/30980618 https://www.proquest.com/docview/2209611470 https://pubmed.ncbi.nlm.nih.gov/PMC6916559 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVEBS databaseName: Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1473-2165 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017915 issn: 1473-2130 databaseCode: ABDBF dateStart: 20020901 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVOVD databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling customDbUrl: eissn: 1473-2165 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017915 issn: 1473-2130 databaseCode: OVEED dateStart: 20020101 isFulltext: true titleUrlDefault: http://ovidsp.ovid.com/ providerName: Ovid |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED_mBuKL-O38GBV9Uaz0a2kDvoy5MQZzPjjZW0nSBAeuFbeBf76XtCsbE8G3ll5KucvlfpdLfwdwg6BBKYdJu5lEiR24ibI5o4ktNLuSojxiphfB4Jn0RkF_3BxX4HH5L0zOD1FuuGnPMOu1dnDGZ6tOnonkQUeraAtqrg77mtc5eClrCCE1_QvcIPRtD5fqgpzUnOMpx66How2MuXlUchXCmhjU3YPdAjxardza-1CR6QFsD4ry-CHctywNAqdWpiy0BUfZ6eRb1wiseWZNzP6BtKYSEfOUHcGo23lt9-yiHYItgohEthAuZyFCLJ8ozMu4okxGic890vQ96SoR4j31WISLWIJ5H1OM6CpogI7AFSf-MVTTLJWnYDGPUSochH6u1FylTAqCiZj0uC8d6pM63C61EouCK1y3rPiIy5wBNRgbDdbhupT9zBkyfpW6Wio3xgmsqxIsldliFnue7jqDVnLqcJIru3yP79AIAQeODtfMUApocuz1J-nk3ZBkE8S9mC3V4c4Y7I9Pi_vD9pO5OvuP8DnsIHii-dGWC6jOvxbyEgHKnDfMPGxAbfjW6Tz9AFgf4dc |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEB58gHoR39ZnRS-KlTbtps1x8cGqu6uHXfBWkjTBBduKruDPd5J2i4sieGvppJSZTPJNZvoNwAmCBq19rrxWlmReFGTaE5xlnjTsSpqJhNteBL0-7Qyju6fWU12bY_6FqfghmgM34xl2vTYObg6kv3t5KbMLs10lszAfUeKbSU2ixyaJEDPbwCCI4tAjuFbX7KS2kKcZO70f_QCZP2slv2NYuwndrMByjR7ddmXuVZhRxRos9Or8-Dqct12DAnO31C4aQ6BsPvo0SQJ3XLoje4Cg3FwhZM75BgxvrgeXHa_uh-DJKKGJJ2UgeIwYK6QaAzOhGVdJFgpCWyFRgZYx3jPCE1zFMgz8uObUpEEj9AShBQ03Ya4oC7UNLiecMekj9guUISvlSlKMxBQRofJZSB04nWgllTVZuOlZ8ZI2QQNqMLUadOC4kX2tKDJ-lTqaKDfFGWzSErxQ5cd7SohpO4NW8h3YqpTdvCf0WYKIA0fHU2ZoBAw79vSTYvRsWbIpAl8Mlxw4swb749PSu4fLK3u18x_hQ1jsDHrdtHvbv9-FJURSrKpz2YO58duH2ke0MhYHdk5-AXvM47A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB5qBfEivo3PiF4UI3l1kwUvRS212upBwVvYJxZsIlrBn-_sJg0tiuAtIbMhzOzsfrMz-QbgGEGD1j5TXkum0osDqT3OqPSEYVfSlKfM9iLoD0j3Ke49t54bcDH5F6bkh6gP3Ixn2PXaOPib1NNOXgh5bnardA7mY8PZYnid44c6h5BQ278giJPIC3GprshJbR1PPXZ2O_qBMX-WSk5DWLsHdZZhqQKPbru09go0VL4KC_0qPb4GZ23XgMCRW2gXbcFRdjT8MjkCd1y4Q3t-oNyRQsQ8Yuvw1Ll-vOx6VTsET8QpST0hAs4ShFgR0RiXcU2ZSmXEQ9KKQhVokeA9DVmKi5jEuI9pRkwWNEZH4JqTaAOaeZGrLXBZyCgVPkK_QBmuUqYEwUBMhTxSPo2IAycTrWSi4go3LSteszpmQA1mVoMOHNWybyVDxq9ShxPlZjiBTVaC5ar4_MjC0HSdQSv5DmyWyq7fE_k0RcCBo5MZM9QChhx79kk-fLEk2QRxL0ZLDpxag_3xaVnv_vLKXm3_R_gAFh6uOtndzeB2BxYRR9GyymUXmuP3T7WHWGXM9-2U_AY_teLi |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+cream+of+herbal+mixture+to+improve+melasma&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Zhang%2C+Qiongyu&rft.au=Tu%2C+Ying&rft.au=Gu%2C+Hua&rft.au=Sun%2C+Dongjie&rft.date=2019-12-01&rft.issn=1473-2130&rft.eissn=1473-2165&rft.volume=18&rft.issue=6&rft.spage=1721&rft.epage=1728&rft_id=info:doi/10.1111%2Fjocd.12938&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jocd_12938 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon |